GLAXOUpdated 30 Aug 2026, 22:27

Glaxosmithkline Pharma Lt

GLAXOUpdated 30 Aug 2026, 22:27

Market Cap

₹52,624Cr.

Current Price

₹3,106

High / Low

₹3,121/2,088

Stock P/E

49.7

ROE43.3%

ROCE61.3%

Book Value₹132

Face Value₹10.0

Dividend Yield1.83%

About

GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site)

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	11	16	21	19	14	11	27	23	22	24	29	26
Inventory Days	89	155	111	147	131	135	153	144	128	146	124	119
Days Payable	74	96	72	148	109	99	131	156	122	174	188	152
Cash Conversion Cycle	26	75	61	18	37	47	49	11	27	-4	-36	-7
Working Capital Days	-49	25	6	-91	-72	-35	-38	-96	-59	-66	-102	-92
ROCE %	41%	28%	22%	26%	31%	33%	37%	36%	36%	51%	63%	61%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 30 August 2026 at 22:27

GLAXOSMITHKLINE PHARMA LT (GLAXO) financials — quarterly results, P&L, cash flow, balance sheet, shareholding